Abstract
A recently developed immunosuppressive substance, 2-chloro-2-deoxyadenosine (2-CdA), was reported to inhibit monocyte functions at low concentration. Because macrophages play a key role in the formation of atherosclerotic plaques, it was of interest to study the effect of 2-CdA on cellular lipid metabolism. For this purpose we have used a macrophage cell line (P388) to perform incubation studies in the presence of acetylated low density lipoprotein (Ac-LDL) and 2-CdA. The addition of 2-CdA, in concentrations ranging from 5–20 nM, induced a dose-dependent decrease in cellular cholesterol content and in the amount of extracellular [14C]oleic acid (OA) incorporated into the cholesteryl ester (CE) fraction. The effect was maximized at 20 nM 2-CdA with an 86% reduction in cholesterol esterification compared to controls (P<0.008). To evaluate the mechanism of interaction of 2-CdA with cellular lipid metabolism, deoxycytidine (dCyt) and 3-methoxybenzamide (3-MOB), substances known to antagonize the effect of 2-CdA in different ways, were co-administered with 2-CdA. dCyt, a competitive inhibitor of dCyt kinase, which catalyzes phosphorylation to the active metabolite, antagonized the effects of 20 nM 2-CdA, producing significantly greater incorporation of extracellular [14C]OA into the CE fraction than in the presence of 2-CdA alone (P<0.0086). Co-incubation with 2-CdA and the poly-ADP-ribose synthetase inhibitor 3-MOB, which is known to render cells resistant to 2-CdA toxicity by preventing cellular nicotinamide adenine dinucleotide (NAD)- and adenosine triphosphase-depletion, also reversed the effect of 2-CdA on lipid accumulation. However, incubation of P388 cells with 20 nM 2-CdA did not result in a decrease in cellular NAD content. As 20 nM 2-CdA showed no effect on intracellular cholesterol synthesis based on measurement by 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, the decrease in cellular cholesterol content and in [14C]OA incorporation seems to be primarily due to an interference with Ac-LDL metabolism.
Similar content being viewed by others
Abbreviations
- ACAT:
-
acyl coenzyme A:cholesterol acyltransferase
- Ac-LDL:
-
acetylated low density lipoprotein
- ADP:
-
adenosine diphosphate
- AMP:
-
adenosine-monophosphate
- 2-CdA:
-
2-chloro-2-deoxyadenosine
- cdATP:
-
chlorodeoxy adenosine triphosphate
- CE:
-
cholesteryl ester
- dCyt:
-
deoxycytidine
- EDTA:
-
ethylenediaminetetraacetic acid
- HMG-CoA:
-
3-hydroxy-3-methylglutaryl coenzyme A
- LDL:
-
low density lipoprotein
- 3-MOB:
-
3-methoxybenzamide
- NAD:
-
nicotinamide adenine dinucleotide
- OA:
-
oleic acid
References
Gerrity, R.G. (1981)Am. J. Pathol. 103, 181–190.
Gown, A.M., Tsukada, T., and Ross, R. (1986)Am. J. Pathol. 125, 191–207.
Goldstein, J.L., Ho, Y.K., Basu, S.M., and Brown, M.S. (1979)Cell Biol. 76, 333–337.
Arai, H., Kita, T., Yokode, M., Narumiya, S., and Kawai, C.H. (1989)Biochem. Biophys. Res. Commun. 159, 1375–1382.
Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudara, P., and Krieger, M. (1990)Nature 343, 531–535.
Steinberg, D., Parthasarathy, S., Carew, T.E., Khoo, J.C., and Witztum, J.L. (1989)N. Engl. J. Med. 320, 915–924.
Brown, M.S., Ho, Y.K., and Goldstein, J.L. (1980)J. Biol. Chem. 255, 9344–9353.
Via, D.P., Plant, A.L., Craig, I.F., Gotto, Jr., A.M., and Smith, L.C. (1985)Biochim. Biophys. Acta 83, 417–428.
Van Lenten, B.J., Fogelman, A.M., Seager, J., Ribi, E., Haberland, M.E., and Edwards, P.A. (1985)J. Immunol. 134, 3718–3721.
Fogelman, A.M., Seager, J., Haberland, M.E., Hokom, M., Tanaka, R., and Edwards, P.A. (1982)Proc. Natl. Acad. Sci. USA 79, 922–926.
Via, D.P., Pons, L., Dennison, D.K., Fanslow, A.E., and Bernini, F. (1989)J. Lipid Res. 30, 1515–1529.
Fogelman, A.M., Haberland, M.E., Seager, J., Hokom, M., and Edwards, P.A. (1981)J. Lipid Res. 22, 1131–1141.
Mazzone, T., and Chait, A. (1982)Arteriosclerosis 2, 487–492.
Geng, Y.J., and Hansson, G.K. (1992)J. Clin. Invest. 89, 1322–1330.
Lippy, E., and Clinton, S.T.K. (1993)Curr. Opin. Lipidol. 4, 355–363.
Lopez-Virella, M.F., Klein, R.L., and Stevenson, H.C. (1987)Arteriosclerosis 7, 176–184.
Hirsch, L.J., and Mazzone, T. (1986)J. Clin. Invest. 71, 485–490.
Beutler, E., Piro, L., Saven, A., Kay, A.C., McMillan, R., Longmire, R., Carrera, C.J., Morin, P., and Carson, D.A. (1991)Leukemia and Lymphoma 5, 1–8.
Carson, D.A., Wasson, D.B., and Beutler, E. (1984)Proc. Natl. Acad. Sci. USA 81, 2232–2236.
Carrera, C.J., Terai, C.H., Lotz, M., Curd, J.C., Piro, L.D., Beutler, E., and Carson, D.A. (1990)J. Clin. Invest. 86, 1480–1488.
Carson, D.A., Wasson, D.B., Kaye, J., Ullmann, B., Martin, Jr., D.W., Robins, R.K., and Montgomery, J.A. (1980)Proc. Natl. Acad. Sci. USA 77, 6865–6874.
Beutler, E. (1992)Lancet 340, 952–956.
Carson, D.A., Kaye, J., and Seegmiller, J.E. (1977)Proc. Natl. Acad. Sci. USA 74, 5677–5681.
Seto, S.H., Carrera, C.J., Kubota, M., Wasson, B., and Carson, D.A. (1985)J. Clin. Invest. 75, 377–380.
Sims, J.L., Sihorsky, G.W., Catino, D.M., Berger, S.J., and Berger, N.A. (1982)Biochemistry 21, 1813–1821.
Bilgeri, R., Petzer, A., Zilian, U., Geisen, E.H., Haun, M., Braunsteiner, H., and Konwalinka, G. (1992)Exp. Haematol. 21, 432–435.
Patsch, J.R., Sailer, S., Kostner, G., Sandhofer, F., Holasek, A., and Braunsteiner, H. (1974)J. Lipid Res. 15, 356–366.
Basu, S.K., Goldstein, J.L., Anderson, R.G., and Brown, M.S. (1976)Proc. Natl. Acad. Sci. USA 79, 1712–1715.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, B.J. (1951)J. Biol. Chem. 193, 265–275.
Harwood, H.J., Schneider, M., and Stacpoole, P.W. (1984)J. Lipid Res. 25, 967–983.
Klocker, H., Auer, B., Hirsch-Kauffmann, M., Altann, H., Burtscher, H.S., and Schweiger, M. (1983)EMBO J. 2, 303–307.
Bell, F.P. (1985)Lipids 20, 75–80.
Middleton, B., and Middleton, A. (1992)Biochem. J. 282, 853–861.
Ueda, K. (1985)Ann. Rev. Biochem. 54, 73–100.
Author information
Authors and Affiliations
About this article
Cite this article
Lechleitner, M., Auer, B., Zilian, U. et al. The immunosuppressive substance 2-chloro-2-deoxyadenosine modulates lipoprotein metabolism in a murine macrophage cell line (P388 cells). Lipids 29, 627–633 (1994). https://doi.org/10.1007/BF02536097
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536097